SCHEMBL7155162

SCHEMBL7155162

CC(C)(C)n1c(C(=O)O)cc2cc([N+](=O)[O-])ccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR2 P41597 3/20 0.51
▸ CYP19A1 P11511 1/20 0.46
▸ TP53 P04637 2/20 0.42
▸ HTT P42858 1/20 0.41
▸ ALDH1A1 P00352 5/20 0.40
▸ MAPT P10636 1/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40
▸ MAOA P21397 1/20 0.40
▸ MAOB P27338 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ MCL1 Q07820 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ NPY1R P25929 1/20 0.38
▸ NPY2R P49146 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3052651 0.81 CYP19A1 (0.59) CCR2CYP19A1ALDH1A1MAPTKDM4E
SCHEMBL29697822 0.79 CCR2 (0.52) CCR2CYP19A1TP53HTTALDH1A1
SCHEMBL28808282 0.78 CCR2 (0.47) CCR2CYP19A1ALDH1A1MAPTMAOA
SCHEMBL1415761 0.78 CCR2 (0.63) CCR2CYP19A1TP53HTTMAPT
SCHEMBL8045718 0.77 CCR2 (0.47) CCR2ALDH1A1MAPTTDP1CYP3A4
SCHEMBL4303543 0.77 MCL1 (0.65) ALDH1A1KDM4EHPGDHSD17B10MCL1
SCHEMBL9541803 0.76 CYP1A2 (0.44) CCR2CYP19A1HTTALDH1A1MAPT
SCHEMBL3638474 0.76 POLB (0.43) TP53HTTALDH1A1MAPTKDM4E
SCHEMBL6018883 0.76 CCR2 (0.61) CCR2CYP19A1TP53HTTALDH1A1
SCHEMBL15712653 0.75 CCR2 (0.60) CCR2CYP19A1TP53HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6534660-B1 Halogenation, alkylation and ring-closure of protected 2-amino-4-hydroxynaphthalene under suitable conditions to provide desired racemate, isolating (-) isomer, removing protecting groups IMMUNOGEN, INC. 2003-03-18 — — US disclosed
Send feedback